Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.
Alvi A RahmanJonathan MichaudSophie Dell'AnielloErica E M MoodieJames M BrophyMadeleine DurandJason Robert GuertinJean-François BoivinChristel RenouxPublished in: Neurology (2022)
This study provides Class II evidence that in patients with NVAF, OAC use (vs nonuse) is associated with a decreased risk of dementia.